Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma.

Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma.
复制标题

DOI:
10.1038/nature07968
复制
发表时间:
2009-06-04
期刊:
影响因子:
64.8
通讯作者:
Pasqualucci, Laura
Pasqualucci, Laura
中科院分区:
综合性期刊1区
文献类型:
--
作者:
Compagno, Mara;Lim, Wei Keat;Grunn, Adina;Nandula, Subhadra V.;Brahmachary, Manisha;Shen, Qiong;Bertoni, Francesco;Ponzoni, Maurilio;Scandurra, Marta;Califano, Andrea;Bhagat, Govind;Chadburn, Amy;Dalla-Favera, Riccardo;Pasqualucci, Laura

文献摘要

参考文献

被引文献

相似文献

弥漫性大B细胞淋巴瘤(DLBCL)是成年期最常见的淋巴瘤形式,包括多种生物学和临床不同的亚型,包括生发中心B细胞样(GCB)和活化B细胞样(ABC) DLBCL。基因表达谱研究表明,其最具侵袭性的亚型ABC-DLBCL与NF-kB转录复合物的组成性激活有关。然而,除了一小部分病例外,目前尚不清楚这些肿瘤中的NF-kB激活是肿瘤细胞起源的内在程序还是发病事件。在这里,我们发现50%的ABC-DLBCL和一小部分的GCB-DLBCL携带多个基因的体细胞突变,包括NF-kB的阴性(TNFAIP3/A20)和阳性(CARD11、TRAF2、TRAF5、MAP3K7/TAK1和TNFRSF11A/RANK)调节因子。其中,A20基因最常受影响,该基因编码一种泛素修饰酶,参与NF-kB反应的终止,约30%的患者因突变和/或缺失而表现出双等位基因失活。当A20重新引入携带双等位基因失活的细胞系时,A20诱导细胞凋亡和细胞生长停滞,表明其肿瘤抑制作用。不太常见的是,TRAF2和CARD11的错义突变会产生显著增强NF-kB激活能力的分子。因此,我们的研究结果表明,DLBCL中NF-kB的激活是由影响多个基因的遗传病变引起的,这些基因的丢失或激活可能通过导致NF-kB反应异常延长来促进淋巴瘤的发生。
Diffuse large B-cell lymphoma (DLBCL), the most common form of lymphoma in adulthood, comprises multiple biologically and clinically distinct subtypes including germinal center B cell-like (GCB) and activated B cell-like (ABC) DLBCL. Gene expression profile studies have shown that its most aggressive subtype, ABC-DLBCL, is associated with constitutive activation of the NF-kB transcription complex. However, except for a small fraction of cases, it remains unclear whether NF-kB activation in these tumors represents an intrinsic program of the tumor cell of origin or a pathogenetic event. Here we show that >50% of ABC-DLBCL and a smaller fraction of GCB-DLBCL carry somatic mutations in multiple genes, including negative (TNFAIP3/A20) and positive (CARD11, TRAF2, TRAF5, MAP3K7/TAK1 and TNFRSF11A/RANK) regulators of NF-kB. Of these, the A20 gene, which encodes for a ubiquitin-modifying enzyme involved in termination of NF-kB responses, is most commonly affected, with ~30% of patients displaying biallelic inactivation by mutations and/or deletions. When reintroduced in cell lines carrying biallelic inactivation of the gene, A20 induced apoptosis and cell growth arrest, indicating a tumor suppressor role. Less frequently, missense mutations of TRAF2 and CARD11 produce molecules with significantly enhanced ability to activate NF-kB. Thus, our results demonstrate that NF-kB activation in DLBCL is caused by genetic lesions affecting multiple genes, whose loss or activation may promote lymphomagenesis by leading to abnormally prolonged NF-kB responses.
DOI: 10.1126/science.289.5488.2350
发表时间: 2000-09-29
期刊: SCIENCE
影响因子: 56.9
作者:
Lee, EG;Boone, DL;Ma, A
通讯作者: Ma, A
DOI: 10.1126/science.272.5259.263
发表时间: 1996-04-12
期刊: SCIENCE
影响因子: 56.9
作者:
Naldini, L;Blomer, U;Trono, D
通讯作者: Trono, D
DOI: 10.1182/blood-2003-12-4291
发表时间: 2004-12-15
期刊: BLOOD
影响因子: 20.3
作者:
Basso, K;Klein, U;Dalla-Favera, R
通讯作者: Dalla-Favera, R
DOI: 10.1126/science.1153629
发表时间: 2008-03-21
期刊: SCIENCE
影响因子: 56.9
作者:
Lenz, Georg;Davis, R. Eric;Staudt, Louis M.
通讯作者: Staudt, Louis M.
DOI: 10.1038/ni1110
发表时间: 2004-10-01
期刊: NATURE IMMUNOLOGY
影响因子: 30.5
作者:
Boone, DL;Turer, EE;Ma, A
通讯作者: Ma, A